Pharmacological treatment options for alcohol use disorder (AUD ) remain limited. GLP-1 receptor agonists are now established treatments for diabetes and obesity, but their effects on the neural pathways involved in appetite and reward have also sparked interest in their potential for treating addictive behavior.
Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Jetzt beitreten
Already a member? Log in here
